England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

Sundar Jagannath, MBBS, highlights long-term follow-up data from the phase 1b/2 CARTITUDE-1 trial, showing durable responses and potential cures with ciltacabtagene autoleucel in patients with ...

GSK’s Blenrep (belantamab mafodotin) has been recommended by the National Institute for Health and Care Excellence (NICE) as ...

A “Trojan horse” therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...

England's blood cancer patients are the first globally to receive a revolutionary 'Trojan horse' drug, belantamab mafodotin, ...

Terminal patients could get years more with their loved ones as the NHS offers Blenrep, which can put some blood cancer ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest. | ITV National News ...

Blood cancer patients in England will be the first in the world to be offered a 'Trojan horse' drug. Thousands of patients ...

England becomes the first country to offer the world’s pioneering 'Trojan horse' blood cancer drug, through NHS, promising ...

A Sheffield man has become one of the first patients in the world to benefit from a pioneering therapy that could halt the ...